United States · FDA National Drug Code directory
LISINOPRIL and HYDROCHLOROTHIAZIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51407-566_fd91c3d4-99e0-4b5d-8f6c-d08f19b64703
- Product NDC
- 51407-566
- Form
- TABLET
- Composition / generic term
- LISINOPRIL and HYDROCHLOROTHIAZIDE
- Labeler
- GSMS, Incorporated
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250215
- Source listing expiry
- 20261231
Source-listed ingredients
- LISINOPRIL — 20 mg/1
- HYDROCHLOROTHIAZIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET in 1 BOTTLE (51407-566-05) · 51407-566-05
- 90 TABLET in 1 BOTTLE (51407-566-90) · 51407-566-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →